Biological Sequence Search

Getting the right results is in our DNA

Our in-depth Biological Sequence Search is designed to unearth even the most hard-to-find sequences hidden deep within a wide array of patent and non-patent literature, making it ideal for Fortune 500s and world-renowned research labs developing antibodies, primers and therapies including peptides/ nucleic acids.

Algorithm-powered Biological Sequence Searches that are cost-effective and time-bound

Perform result-oriented Biological Sequence Search to:

  • To discover relevant biological sequences whose gene name and name of the peptide/ antibody are not disclosed in references.
  • To discover relevant patents with precision by identifying the results based on the homology of the sequences, wherein, the similarity is derived from common ancestry and conservation throughout evolution
  • To strengthen Patentability Search, Invalidity Search, Freedom-To-Operate Search and Landscape Analysis.

Aimed at the Pharmaceutical and Life Sciences industries, Sagacious IP’s Biological Sequence Search supports R&D professionals in their quest to innovate, enables researchers to do better research and lets IP councils protect their client’s IP.

Why us?

  • 1,000+ Chemical Structure Searches conducted every year.
  • Multi-Level Quality Checks
  • Relevant Substitution Details for Markush Structures
  • More than 16+ Languages Covered in Searches
  • Low-Pricing, Quick Turn Around Time and Absolute Transparency
  • Access to 5+ State-of-Art Databases

Testimonials

Impact Stories

Impact Story 1

When one of the World’s Top Antibody producing Company wanted to have an expert opinion on the Freedom to Operate for an antibody developed in-house and its subsequent potential, they chose Sagacious.

Impact Story 2

When a global leader in Healthcare wanted to market one of their high potential therapy involving a recent developed marker an antibody, they chose Sagacious.

Impact Story 3

When an oncology-based company, wanted to enquire about the recent therapies developed for the cancer treatment and check if their developed therapy aligns to any prevalent one, they chose Sagacious.

Impact Story 4

When a Swiss Company wanted to test the novelty of one of its developed oligonucleotide and wanted to subsequently explore the related applications in the market of interest, they chose Sagacious,

Join 100+ Pharmaceutical and Life Sciences Companies in Trusting Sagacious IP for Chemical Structure Searches

Input your details:

Input your details:

Input your details:

Input your details:

Input Your Details